StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report released on Sunday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of Ampio Pharmaceuticals stock opened at $0.00 on Friday. The firm’s fifty day simple moving average is $0.08 and its 200-day simple moving average is $0.69. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $7.47. The stock has a market capitalization of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 2.21.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.